| Report ID | Date of report | Patient age | Patient gender |
| 30041 | Jan, 24, 2006 | 49 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Vioxx | rofecoxib |
Norvasc | amlodipine besylate |
Cardura | doxazosin mesylate |
Lotensin | benazepril hydrochloride |
Pravachol | pravastatin sodium |
Bumex | bumetanide |
| Name |
Abdominal Pain |
Abscess |
Anaemia |
Arthralgia |
Arthropathy |
Asthenia |
Back Pain |
Blindness |
Cardiac Murmur |
Cerebrovascular Accident |
Diabetic Gastroenteropathy |
Diabetic Retinopathy |
Dialysis |
Dizziness |
Dysarthria |
Dyspnoea |
Gastritis |
Headache |
Hiatus Hernia |
Hypoglycaemia |
Impaired Gastric Emptying |
Inguinal Mass |
Injury |
Intestinal Functional Disorder |
Nausea |
Oesophagitis |
Renal Disorder |
Renal Failure |
Sexual Dysfunction |
Vomiting |
Results from eHealthMe : 3 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Abdominal Pain | 3 (100.00%) |
Abscess | 1 (33.33%) |
Anaemia | 2 (66.67%) |
Arthralgia | 1 (33.33%) |
Arthropathy | 2 (66.67%) |
Asthenia | 1 (33.33%) |
Back Pain | 1 (33.33%) |
Blindness | 2 (66.67%) |
Cardiac Murmur | 1 (33.33%) |
Cerebrovascular Accident | 3 (100.00%) |
Diabetic Gastroenteropathy | 2 (66.67%) |
Diabetic Retinopathy | 1 (33.33%) |
Dialysis | 1 (33.33%) |
Dizziness | 3 (100.00%) |
Dysarthria | 3 (100.00%) |
Dyspnoea | 3 (100.00%) |
Gastritis | 2 (66.67%) |
Headache | 1 (33.33%) |
Hiatus Hernia | 2 (66.67%) |
Hypoglycaemia | 2 (66.67%) |
Impaired Gastric Emptying | 2 (66.67%) |
Inguinal Mass | 2 (66.67%) |
Injury | 1 (33.33%) |
Intestinal Functional Disorder | 3 (100.00%) |
Nausea | 3 (100.00%) |
Oesophagitis | 2 (66.67%) |
Renal Disorder | 3 (100.00%) |
Renal Failure | 3 (100.00%) |
Sexual Dysfunction | 2 (66.67%) |
Vomiting | 3 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Nausea | 3 (100.00%) |
Renal Disorder | 3 (100.00%) |
Renal Failure | 3 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
